{"id":"W3214093530","doi":"10.1182/blood-2021-153571","title":"A Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia: Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Decitabine; Chemotherapy regimen; Regimen; Gastroenterology; Myeloid leukemia; Myeloid; Chemotherapy; Leukemia; Oncology; Chemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00116935,0.0007930676,0.001941058,0.000266045,0.0003088697,0.0006485092,0.0005566945,0.0008277947,0.002013491],"category_scores_gemma":[0.0005761876,0.0003548644,0.001255832,0.0003765112,0.0005334591,0.0006728452,0.0002227767,0.001999202,0.0004224928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006951523,"about_ca_system_score_gemma":0.0008906666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009583798,"about_ca_topic_score_gemma":0.002638295,"domain_scores_codex":[0.9996194,0.0001679966,0.0000313591,0.00007896606,0.00004103767,0.00006137157],"domain_scores_gemma":[0.9994408,0.00009093443,0.0001337346,0.00004747762,0.00003006574,0.0002570376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6849996,0.06215027,0.01950478,0.001440813,0.00440973,0.0003403999,0.0003846972,0.002904122,0.06148712,0.0001520979,0.003295264,0.1589311],"study_design_scores_gemma":[0.3765289,0.5710678,0.04252565,0.00006378125,0.001996533,0.0005178603,0.00007780419,0.001198741,0.003444836,0.00009593363,0.002443067,0.00003900257],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960182,0.002398312,0.0001704551,0.0001304241,0.00004132159,0.0003825601,0.0002877438,0.00003360889,0.0005373931],"genre_scores_gemma":[0.9957736,0.00164783,0.0005809159,0.0002944319,0.000101909,0.0003612736,0.0006858283,0.00001116019,0.0005430873],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002013491,"threshold_uncertainty_score":0.006735861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01592817073836526,"score_gpt":0.2888111067648463,"score_spread":0.2728829360264811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}